Stock News - Cadrenal Therapeutics, Inc. $CVKD
Latest Stock News for $CVKD
Cadrenal Therapeutics Announces Warrant Inducement Agreement to Raise $2.5 Million
Expected Stock impact: Slightly Positive
2026-04-01 11:41:36
Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results and Corporate Update
Expected Stock impact: Slightly Positive
2026-03-31 12:56:10
Cadrenal Therapeutics Announces Promising Pre-Clinical Research on CAD-1005 for Obesity and Diabetes
Expected Stock impact: Noticeably Positive
2026-03-12 16:52:20
